Ursodeoxycholic acid (UDCA), a clinically available compound, restores mitochondrial quality in aged oocytes by upregulating EGR1, a transcription factor that coordinates cellular cleanup mechanisms. This identifies a tractable molecular pathway for addressing reproductive aging at its regulatory source rather than at the level of downstream dysfunction.
Key Points
- EGR1 downregulation drives oocyte aging via impaired mitochondrial autophagy
- UDCA restores EGR1 expression and mitochondrial clearance capacity
- EGR1 inhibition abolishes UDCA's protective effect on egg quality
Longevity Analysis
Reproductive aging reflects systemic energetic decline—mitochondria in egg cells accumulate damage over time, reducing cellular power production and developmental competence. This work moves beyond treating symptoms of aged eggs toward identifying the upstream regulatory switch that controls whether cells actively remove damaged mitochondria. By restoring a single transcription factor, UDCA appears to reactivate the cellular machinery responsible for maintaining mitochondrial integrity. For reproductive lifespan and broader aging biology, this demonstrates that age-related cellular dysfunction often stems from diminished capacity for self-maintenance, not irreversible damage—and that capacity can be pharmacologically recovered. The translational implication is significant: UDCA is already in clinical use for other conditions, making human application immediately feasible.
Original published by Wiley Aging Cell, by Ying Zhang, Qianru Han, Yongchao Liu, Wei Shen, Shunfeng Cheng, Xiaoya Li .